Fuji Keizai Releases Report on Specified Health Food Market in Japan.
The report estimates that the market reached 342.1 billion yen ($3.1 bil) in 2004 and is expected to reach 377.1 billion yen ($3.4 bil) in 2006.
The report identifies some growing segments: alpha-lipoic acid, gamma aminobutyric acid (GABA), and vegetable supplements. The alpha-lipoic acid segment leaped from 60 million yen ($535,000) in 2004 to 7.7 billion yen ($68 mil) in 2006; the GABA segment will leap more than sixfold from 2.6 billion yen ($23 mil) to 16.4 billion yen ($146 mil); the vegetable supplement segment will more than double from 6.1 billion yen ($54 mil) to 15 billion yen ($134 mil).
Entitled "Market of Specified Health Foods and Promising Ingredients 2005," the 191-page report, available only in Japanese, sells for 105,000 yen ($937) in hardcopy and 115,500 yen ($1,030) with a supplemental CD-ROM.
Source: JCN http://www.japancorp.net
Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Oct 4, 2005|
|Previous Article:||Interwired Announces Results of Survey on Drugs and First-aid Boxes.|
|Next Article:||Kyowa Hakko Chemical to Increase Production Capacity of 2-Ethyl Hexanoic Acid.|